Showing results (71-80 of 82) with videos related to
Sort By:
Pageof 9
The Journal of Biological Chemistry|March 30, 2001
Cell cycle and biochemical effects of PD 0183812. A potent inhibitor of the cyclin D-dependent kinases CDK4 and CDK6D W Fry, D C Bedford, P H Harvey, et al.Journal of Medicinal Chemistry|January 6, 1995
Tyrosine kinase inhibitors. 4. Structure-activity relationships among N- and 3-substituted 2,2'-dithiobis(1H-indoles) for in vitro inhibition of receptor and nonreceptor protein tyrosine kinasesB D Palmer, G W Rewcastle, A M Thompson, et al.Journal of Medicinal Chemistry|December 16, 1997
Tyrosine kinase inhibitors. 13. Structure-activity relationships for soluble 7-substituted 4-[(3-bromophenyl)amino]pyrido[4,3-d]pyrimidines designed as inhibitors of the tyrosine kinase activity of the epidermal growth factor receptorA M Thompson, D K Murray, W L Elliott, et al.Journal of Medicinal Chemistry|February 16, 1996
Tyrosine kinase inhibitors. 9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP site inhibitors of the tyrosine kinase activity of the epidermal growth factor receptorG W Rewcastle, B D Palmer, A J Bridges, et al.Cancer Chemotherapy and Pharmacology|February 9, 2000
Anticancer efficacy of the irreversible EGFr tyrosine kinase inhibitor PD 0169414 against human tumor xenograftsP W Vincent, A J Bridges, D J Dykes, et al.Neoplasia (New York, N.Y.)|September 26, 2001
Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytesS W Stoll, S Kansra, S Peshick, et al.Journal of Medicinal Chemistry|March 26, 1998
Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factorsG W Rewcastle, D K Murray, W L Elliott, et al.Journal of Medicinal Chemistry|July 21, 2001
Tyrosine kinase inhibitors. 18. 6-Substituted 4-anilinoquinazolines and 4-anilinopyrido[3,4-d]pyrimidines as soluble, irreversible inhibitors of the epidermal growth factor receptorJ B Smaill, H D Showalter, H Zhou, et al.Proceedings of the National Academy of Sciences of the United States of America|September 30, 1998
Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitorD W Fry, A J Bridges, W A Denny, et al.Journal of Medicinal Chemistry|February 14, 1997
Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congenersH D Showalter, A D Sercel, B M Leja, et al.Pageof 9